233 related articles for article (PubMed ID: 11355942)
1. Mutant epidermal growth factor receptor enhances induction of vascular endothelial growth factor by hypoxia and insulin-like growth factor-1 via a PI3 kinase dependent pathway.
Clarke K; Smith K; Gullick WJ; Harris AL
Br J Cancer; 2001 May; 84(10):1322-9. PubMed ID: 11355942
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor receptor transcriptionally up-regulates vascular endothelial growth factor expression in human glioblastoma cells via a pathway involving phosphatidylinositol 3'-kinase and distinct from that induced by hypoxia.
Maity A; Pore N; Lee J; Solomon D; O'Rourke DM
Cancer Res; 2000 Oct; 60(20):5879-86. PubMed ID: 11059786
[TBL] [Abstract][Full Text] [Related]
3. PTEN mutation and epidermal growth factor receptor activation regulate vascular endothelial growth factor (VEGF) mRNA expression in human glioblastoma cells by transactivating the proximal VEGF promoter.
Pore N; Liu S; Haas-Kogan DA; O'Rourke DM; Maity A
Cancer Res; 2003 Jan; 63(1):236-41. PubMed ID: 12517803
[TBL] [Abstract][Full Text] [Related]
4. Phosphatidylinositol 3'-kinase and MAPK/ERK kinase 1/2 differentially regulate expression of vascular endothelial growth factor in human malignant astrocytoma cells.
Woods SA; McGlade CJ; Guha A
Neuro Oncol; 2002 Oct; 4(4):242-52. PubMed ID: 12356354
[TBL] [Abstract][Full Text] [Related]
5. Oncogenes and tumor angiogenesis: differential modes of vascular endothelial growth factor up-regulation in ras-transformed epithelial cells and fibroblasts.
Rak J; Mitsuhashi Y; Sheehan C; Tamir A; Viloria-Petit A; Filmus J; Mansour SJ; Ahn NG; Kerbel RS
Cancer Res; 2000 Jan; 60(2):490-8. PubMed ID: 10667605
[TBL] [Abstract][Full Text] [Related]
6. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.
Petit AM; Rak J; Hung MC; Rockwell P; Goldstein N; Fendly B; Kerbel RS
Am J Pathol; 1997 Dec; 151(6):1523-30. PubMed ID: 9403702
[TBL] [Abstract][Full Text] [Related]
7. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
Blancher C; Moore JW; Robertson N; Harris AL
Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
[TBL] [Abstract][Full Text] [Related]
8. Insulin and insulin-like growth factor-I induce vascular endothelial growth factor mRNA expression via different signaling pathways.
Miele C; Rochford JJ; Filippa N; Giorgetti-Peraldi S; Van Obberghen E
J Biol Chem; 2000 Jul; 275(28):21695-702. PubMed ID: 10777488
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia.
Jin KL; Mao XO; Greenberg DA
Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10242-7. PubMed ID: 10963684
[TBL] [Abstract][Full Text] [Related]
10. Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines.
Bancroft CC; Chen Z; Yeh J; Sunwoo JB; Yeh NT; Jackson S; Jackson C; Van Waes C
Int J Cancer; 2002 Jun; 99(4):538-48. PubMed ID: 11992543
[TBL] [Abstract][Full Text] [Related]
11. Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction.
Masuda M; Suzui M; Lim JT; Deguchi A; Soh JW; Weinstein IB
J Exp Ther Oncol; 2002; 2(6):350-9. PubMed ID: 12440226
[TBL] [Abstract][Full Text] [Related]
12. The oncogene phosphatidylinositol 3'-kinase catalytic subunit alpha promotes angiogenesis via vascular endothelial growth factor in ovarian carcinoma.
Zhang L; Yang N; Katsaros D; Huang W; Park JW; Fracchioli S; Vezzani C; Rigault de la Longrais IA; Yao W; Rubin SC; Coukos G
Cancer Res; 2003 Jul; 63(14):4225-31. PubMed ID: 12874030
[TBL] [Abstract][Full Text] [Related]
13. Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1.
Jiang BH; Jiang G; Zheng JZ; Lu Z; Hunter T; Vogt PK
Cell Growth Differ; 2001 Jul; 12(7):363-9. PubMed ID: 11457733
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells.
Bachelder RE; Crago A; Chung J; Wendt MA; Shaw LM; Robinson G; Mercurio AM
Cancer Res; 2001 Aug; 61(15):5736-40. PubMed ID: 11479209
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor gene expression in the human breast cancer cell line MX-1 is controlled by O2 availability in vitro and in vivo.
Marxsen JH; Schmitt O; Metzen E; Jelkmann W; Hellwig-Bürgel T
Ann Anat; 2001 May; 183(3):243-9. PubMed ID: 11396794
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor mediated angiogenic potential of pancreatic ductal carcinomas enhanced by hypoxia: an in vitro and in vivo study.
Sipos B; Weber D; Ungefroren H; Kalthoff H; Zühlsdorff A; Luther C; Török V; Klöppel G
Int J Cancer; 2002 Dec; 102(6):592-600. PubMed ID: 12448000
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor acts as a pericyte mitogen under hypoxic conditions.
Yamagishi S; Yonekura H; Yamamoto Y; Fujimori H; Sakurai S; Tanaka N; Yamamoto H
Lab Invest; 1999 Apr; 79(4):501-9. PubMed ID: 10212003
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-induced metastasis of human melanoma cells: involvement of vascular endothelial growth factor-mediated angiogenesis.
Rofstad EK; Danielsen T
Br J Cancer; 1999 Aug; 80(11):1697-707. PubMed ID: 10468285
[TBL] [Abstract][Full Text] [Related]
19. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis.
Welsh SJ; Bellamy WT; Briehl MM; Powis G
Cancer Res; 2002 Sep; 62(17):5089-95. PubMed ID: 12208766
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic transformation and hypoxia synergistically act to modulate vascular endothelial growth factor expression.
Mazure NM; Chen EY; Yeh P; Laderoute KR; Giaccia AJ
Cancer Res; 1996 Aug; 56(15):3436-40. PubMed ID: 8758908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
